An investment firm comprised of former Fortune 500 executives, industry leaders, and serial entrepreneurs that invests in breakthrough technologies and innovative founders.

Goose Capital

GOOSE Capital is a Houston based investment group comprised of highly successful operators and investors.  GOOSE has invested over $55 million in early-stage venture deals and has had many successful exits.  The group invests around $10 million annually across a variety of industries, but with a focus on breakthrough, defendable technologies.  

GOOSE Capital

🌟PRODUCTION ALERT🌟
In a major milestone, Syzygy and RTI International achieve first fuel from greenhouse gases.⛽

Syzygy's all-electric CO2-to-Fuel pathway can significantly decarbonize transportation by converting two potent greenhouse gases, carbon dioxide (CO2) and methane (CH4), into low-carbon-intensity fuels that can be used to lower the carbon footprint of fossil-based jet fuel, diesel, and gasoline. 

This project marks the successful integration of multiple Syzygy reactor cells in a multi-cell stack at a third-party site, demonstrating Syzygy’s pathway for scaling its technology. At commercial scale, a typical Syzygy plant will consume nearly 200,000 tons of CO2 per year, the equivalent of taking 45,000 cars off the road. 

Huge thanks to project sponsors Equinor Ventures and Sumitomo Corporation of Americas! 

https://hubs.ly/Q02x3YLG0

And a sincere thank you to the Syzygy team.

Hari Thirumalai, PhD
Harshita Kethireddy
Jack Hudson
Arturo Quezada
Zachary Hernandez
Kirk Harstad
David Vallejo
Marshall Hancock
Matoya sherman
Christian Godinez
LeRoy Holmes
Ruben Vela
Jonathan Payne
Madhav Acharya 

#Sustainability #Cleantech #SyntheticFuel

🚀 Exciting News from Vivalyx! 🚀

We are thrilled to announce the successful closure of our oversubscribed Seed funding round, raising over €5 million! This marks a pivotal moment for us as we finance the clinical studies for our groundbreaking organ preservation technology.

A heartfelt thank you to our new and existing investors, including Brightlands Venture Partners, TVF | TechVision Fonds, GOOSE Capital, Andrej Henkler, Angel Invest, Arve Capital and Springboard Health Angels. Your faith in our vision energizes our mission to revolutionize organ transplantation.

Read more about how we're planning to extend vitality of donor organs for a significant impact on healthcare systems worldwide.

https://lnkd.in/ecXWM63P

Have you considered organ donation for yourself? Join the discussion and share your thoughts! 💙
 
Our supporters: Alexander Luik, Priv.-Doz. Dr. med. Alexander Younsi, FEBNS, Andreas Schmidt (PhD.), Andrej Henkler, Angel Invest (Jens Lapinski, John von Berenberg-Consbruch), Ariel Dora Stern, Arve Capital (Christian Schierholz, Philipp Harnischfeger), Ashok Rao, Audrey Tsang, Bernd Heinrichs, Brightlands Venture Partners (Luc Starmans), Dr. Carina Ruwolt, Christian Stiebner, Christopher Oezbek, Dr. Daniel Schellong, David Greenberg, GOOSE Capital (Andrew Nicholson), Ingo Hillen, Jan Adams, Katharina Klohe, Klaus-Dieter Langner, Lisa Ernst, Nicolas Weber, Dr. Ole Dammann, Sebastian Johnston, Till Erdmann, Troy Dale, TVF | TechVision Fonds (Bernhard Kugel, Dr. Lars Gussen), Dr. Valentin Schmitt, Dr. Yoni Goldwasser
 
#Vivalyx #TechnologySavesTheWorld #MedTech #OrganTransplantation #OrganDonation #Innovation #LifeScience

Calyx Global is driving quality in the carbon credit markets and gaining recognition as having one of the most comprehensive databases available to buyers. Reach out to Duncan van Bergen or Donna Lee if you're interested in learning more about the Calyx Global platform. Read the independent report "Rating the Raters" by Carbon Market Watch here:

Metric
Company Name	Goose Capital
Symbol
MSH ID	CAPITAL:GOOSE
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	US
Stage
Employee Count	8
Website	goose.capital
LinkedIn	goosecapital
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	599
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

GOOS

CAPITAL:GOOSE

Goose Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue